Literature DB >> 25093484

Mood disorders in restless legs syndrome (Willis-Ekbom disease).

Philip M Becker1, Denise Sharon.   

Abstract

OBJECTIVE: Restless legs syndrome (RLS), also known as Willis-Ekbom disease, is a sensorimotor disorder that can result in considerable sleep disruption. This narrative review provides an overview of RLS diagnosis and reports epidemiologic evidence for an association between RLS and mood disorders. Possible links between RLS, sleep disturbances, and mood disorders are considered, and theoretical pathophysiologic pathways are discussed. Finally, pharmacologic therapies for RLS are summarized. DATA SOURCES: A PubMed search was performed using the search term restless legs syndrome in combination with affective/anxiety, antidepressants, anxiety/anxiety disorder, attention deficit hyperactivity disorder, depression/depressive disorder, mood/mood disorder, neuropsychiatric, panic/panic disorder, psychiatric disorder, and psychosis. English-language articles published between January 1993 and May 2013 were retrieved. Additional studies were identified from the reference lists of relevant publications. STUDY SELECTION: 173 publications were retrieved. Articles related to the association between idiopathic RLS and depression, anxiety, and mood disorders were reviewed. In total, 32 epidemiologic studies were identified. These studies were reviewed in detail and ranked according to quality. DATA EXTRACTION: Data were extracted on the basis of relevance to the topic. Epidemiologic studies were assessed using 3 parameters: methodology, data quality, and generalizability of the results. Each factor was scored from 1 (high quality) to 4 (low quality), giving a total score of between 3 and 12 for each study. RESULTS AND
CONCLUSIONS: RLS and mood disorders are frequently comorbid. Recognition and appropriate treatment of comorbid RLS are particularly important in patients with psychiatric disorders, as RLS is a common medical reason for insomnia, and antidepressant use may exacerbate sensory symptoms. © Copyright 2014 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2014        PMID: 25093484     DOI: 10.4088/JCP.13r08692

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  12 in total

1.  Impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, and quality of life.

Authors:  Katharina A Schindlbeck; Janek Becker; Felix Berger; Arne Mehl; Charlotte Rewitzer; Sarah Geffe; Peter M Koch; Jan C Preiß; Britta Siegmund; Jochen Maul; Frank Marzinzik
Journal:  Int J Colorectal Dis       Date:  2016-10-18       Impact factor: 2.571

Review 2.  Sleep Abnormalities in Multiple Sclerosis.

Authors:  Giorgos K Sakkas; Christoforos D Giannaki; Christina Karatzaferi; Mauro Manconi
Journal:  Curr Treat Options Neurol       Date:  2019-01-31       Impact factor: 3.598

Review 3.  Restless legs syndrome-current therapies and management of augmentation.

Authors:  Claudia Trenkwalder; Juliane Winkelmann; Yuichi Inoue; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

4.  The prevalence and clinical characteristics of restless legs syndrome in patients with iron deficiency anemia in Korea.

Authors:  Hyoeun Bae; Keun Tae Kim; Mi Hwa Heo; Young-Rok Do; Yong Won Cho
Journal:  J Clin Sleep Med       Date:  2021-07-01       Impact factor: 4.324

5.  Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension.

Authors:  Wolfgang H Oertel; Yngve Hallström; Gerda M Saletu-Zyhlarz; Michael Hopp; Björn Bosse; Claudia Trenkwalder
Journal:  CNS Drugs       Date:  2016-08       Impact factor: 5.749

Review 6.  Suicidality in sleep disorders: prevalence, impact, and management strategies.

Authors:  Christopher W Drapeau; Michael R Nadorff
Journal:  Nat Sci Sleep       Date:  2017-09-14

7.  Restless legs syndrome and tension-type headache: a population-based study.

Authors:  Pil-Wook Chung; Soo-Jin Cho; Won-Joo Kim; Kwang Ik Yang; Chang-Ho Yun; Min Kyung Chu
Journal:  J Headache Pain       Date:  2017-04-19       Impact factor: 7.277

8.  Restless Legs Syndrome in Chinese Patients With Sporadic Amyotrophic Lateral Sclerosis.

Authors:  Shuangwu Liu; Dongchao Shen; Hongfei Tai; Ning Su; Qingyun Ding; Hanhui Fu; Kang Zhang; Zhili Wang; Mingsheng Liu; Yan Huang; Liying Cui
Journal:  Front Neurol       Date:  2018-08-30       Impact factor: 4.003

9.  Relationship between quality of life and restless legs syndrome among a community-dwelling population in Japan.

Authors:  Kazutoshi Kubo; Norio Sugawara; Ayako Kaneda; Ippei Takahashi; Kazuhiko Nakamura; Shigeyuki Nakaji; Norio Yasui-Furukori
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-12       Impact factor: 2.570

Review 10.  Incidence of Augmentation in Primary Restless Legs Syndrome Patients May Not Be That High: Evidence From A Systematic Review and Meta-Analysis.

Authors:  Guang Jian Liu; Lang Wu; Song Lin Wang; Li Ding; Li Li Xu; Yun Fu Wang; Li Ying Chang
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.